Article Details
Retrieved on: 2025-05-08 19:58:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vaccines, gene therapies, monoclonal antibodies, blood products — all pass through CBER on their path to approval. During the COVID-19 pandemic, this ...
Article found on: blogs.jwatch.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here